Abstract:Objectives: To investigate the effect of pH and buffers on the degradation rate of flucloxacillin and to determine if flucloxacillin can be stabilised using a buffered diluent for up to 14 days when stored at 2°C-8°C including a 24-hour infusion period at 32°C in two elastomeric devices (Accufuser and INfusor LV) filled to 240 mL. Testing as per the NHS Pharmaceutical Quality Assurance Committee Yellow Cover Document (YCD) requirements. Methods: A validated stability indicating high-performance liquid chromatography method was used for assessing the stability of flucloxacillin diluted in 0.3% w/v citrate-buffered saline pH 7.0 when stored at 2°C-8°C in two ambulatory devices (Accufuser and INfusor LV). Flucloxacillin at 10 and 50 mg/mL diluted in 0.3% w/v citrate-buffered saline pH 7.0 to a final volume of 240 mL and stored at 2°C-8°C, including 24 hours at 32°C, was tested from two batches in replicate (n=3) at five time points for up to 14 days according to the requirements of the YCD. Results: Greater than 95% of the zero-time concentration of flucloxacillin at 10 and 50 mg/mL remained when stored at 2°C-8°C after 14 days including 24 hours at 32°C in both Accufuser and INfusor LV devices. Conclusions: Flucloxacillin sodium stability was improved, and complied with UK national standards, by using a diluent of 0.3% w/v citrate-buffered saline pH 7 in both Accufuser and INfusor LV ambulatory devices when filled to 240 mL. The data support assigning a shelf-life of up to 14 days (13 days stored at 2°C-8°C and 24 hours at 32°C). Flucloxacillin may now be used appropriately as a continuous 24-hour infusion in outpatient parenteral antimicrobial therapy services, providing further opportunity to avoid or shorten patient hospital stays, as well as support ideal antimicrobial stewardship principles.

Stability of cefsulodin in aqueous buffered solutions and some intravenous admixtures

Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures

Chemical stability of cefotetan disodium in 5% dextrose and 0.9% sodium chloride injections

Absorption, distribution and excretion of cefsulodin, an antipseudomonal cephalosporin, in mice, rats and dogs

Investigation of the Stability of Cefotaxime Sodium Intracutaneous Injection

Validation and Comparative In-vitro Dissolution Studies of Cefaclor in Their Powder for Oral Suspension Dosage Forms

Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting

Stability of Cefazolin Sodium for Injection Compatible with Fat Emulsion and Effects on Its in Vitro and in Vivo Antifungal Activity

Formulation and Evaluation of pH-Modulated Amorphous Solid Dispersion-Based Orodispersible Tablets of Cefdinir

Study on Stability and Compatibility of Potassium Sodium Dehydroandroan Drographolide Succinate for Injection with Ceftezole Sodium in Normal Saline

A Comparative Solubility Enhancement Study of Cefixime Trihydrate Using Different Dispersion Techniques

Systematic approach to the determination of cephalosporins in biological fluids by reversed-phase liquid chromatography

Stability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injections

Improved Synthesis of Cefsulodin

A New Kinetic Approach. Stability of Cefquinome Sulfate under Variable Ph and Temperature

Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability

Synthesis, Characterization, Bioavailability and Antimicrobial Studies of Cefuroxime-Based Organic Salts and Ionic Liquids

Intermolecular Interactions of Cefotaxime with Sodium Alginate Biopolymer in Aqueous Solutions

The stability of cefprozil in oral suspension CEFZIL

Development of Thin-Layer Chromatography–Densitometric Procedure for Qualitative and Quantitative Analyses and Stability Studies of Cefazolin

Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements